Nasal Decongestant Recalled Due to Bacteria Contamination

In a news statement, Insight Pharmaceuticals, in cooperation with the US Food and Drug Administration (FDA), announced the voluntary recall of their Nostrilla Nasal Decongestant (oxymetazoline) spray due to the potential for bacterial contamination.

This recall affects 34,092 bottles of the nasal decongestant spray. The spray is used by consumers to relieve the nasal discomfort caused by colds and other inflammatory issues. This recall was initiated after it was discovered that these bottles could potentially be contaminated with the bacteria Burkholderia cepacia, which is capable of causing serious infection in consumers with compromised immune systems or chronic lung conditions. Nostrilla was available nationwide at various retail outlets and pharmacies. The spray came in half ounce, plastic bottles marked with an expiration date of May 2014. The affected units are a part of the 11G075 lot and have a UPC code of 6373673005.

The company is asking that consumer who have purchased the recalled item not use it and return it to the company for a full refund. Neither the FDA nor Insight Pharmaceuticals has received any reports of illness in relation to this recall at the time of this report.

As an Everett personal injury attorney, I’ve seen many similar recalls in the past and understand the devastating effects they can have on consumers. If you’ve been injured through the use of a defective medical product, it may be in your best interest to speak with a personal injury lawyer in your city.